γδ T Cells Contribute to Injury in the Developing Brain

Anna-Maj Albertsson1, Xiaoli Zhang2, Regina Vontell3

  • 1Perinatal Center, Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Insights

Gamma delta T (γδT) cells initiate brain injury in premature infants, independent of common cytokines. Depleting these cells protected mice, suggesting new therapeutic targets for neonatal brain injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Neonatal Medicine

Background:

  • Perinatal brain injury, particularly periventricular leukomalacia, causes significant neurologic disabilities in premature infants.
  • Inflammation is implicated in perinatal brain injury, but key mediators in early-life brain damage are not fully understood.
  • Neonates have limited conventional alpha-beta T-cell responses, while gamma-delta T (γδT) cells are crucial for early immunity.

Purpose of the Study:

  • To investigate the role of γδT cells in the development of preterm brain injury.
  • To identify the specific mechanisms by which γδT cells contribute to neonatal brain damage.

Main Methods:

  • Analysis of postmortem brains from human preterm infants with periventricular leukomalacia.
  • Utilized a hypoxic-ischemic mouse model and a fetal sheep asphyxia model of preterm brain injury.
  • Examined γδT cell infiltration and depletion effects in animal models, assessing cytokine production.

Main Results:

  • Significant infiltration of γδT cells was observed in the brains of injured preterm infants, mice, and sheep.
  • Depletion of γδT cells conferred protection in the mouse model of preterm brain injury.
  • Common γδT cell cytokines (IFN-γ, IL-17A) were undetectable; IL-17F and IL-22 did not contribute to injury despite increased mRNA levels.

Conclusions:

  • γδT cells act as initiators of preterm brain injury, distinct from their role in mature brain injury.
  • This injury mechanism operates independently of canonical γδT cell-associated cytokines.
  • Findings identify γδT cells as potential therapeutic targets for preventing or treating brain injury in premature infants.